With Support from AWS, Yseop Develops a Unique Generative AI Application for Regulatory Document Generation Across BioPharma
2024年5月2日 - 10:00PM
Yseop, a world leading Artificial Intelligence (AI) software
company and pioneer in Generative AI, with support from Amazon Web
Services (AWS), today announced the development of an enhanced
Generative AI application for the Biopharma industry. Yseop, a
member of the AWS Partner Network (APN), has leveraged AWS for its
security and scalability from day one and is now expanding its use
to benefit its Large Language Model (LLM) ecosystem, infrastructure
and tech expertise. Yseop, with the support of AWS, is empowering
the world’s top Biopharma companies to bring pharmaceuticals and
vaccines to market even faster.
Using AWS, Yseop is now able to embed LLM models for generating
broader scientific content while meeting the security requirements
of the pharmaceutical industry. Ultimately, with AWS and Yseop,
scientific and medical writers within the world’s largest pharma
companies can supercharge their productivity and accelerate the
speed at which therapeutics get into the hands of those who need
them most.
“Yseop has built a unique Generative AI platform for regulatory
document generation that can increase the rate at which new drugs
are introduced, while addressing top concerns like security,
performance, and data localization” said Emmanuel Walckenear, CEO
of Yseop. “Our work with AWS helps us tremendously and solidifies
our leadership position further. With the profound infrastructure
from AWS, we show existing and future clients that Yseop is working
with proven solutions, and we greatly value our collaboration with
them.”
“Yseop and AWS are working together to democratize access to
generative AI and deliver a unique business value to the life
sciences sector, while navigating challenges like scalability and
trust.” said Miguel Alava, AWS Managing Director, Software
Companies EMEA. “Yseop can now leverage capabilities like Amazon
Sagemaker and Amazon Bedrock to meet the strict AI software and
data requirements across Biopharma."
Key benefits through Yseop with AWS in
Biopharma:
- Accelerate time-to-value through a ready to go SaaS enterprise
platform powered by AWS
- Scale content generation safely across organizations thanks to
AWS managed services and tooling - Amazon EKS, Amazon RDS and
Infrastructure as Code CDK
- Manage end-to-end data and document flows with enhanced
security features
- Benefit from the latest advanced AI capabilities with a model
agnostic SaaS powered by AWS SageMaker, AWS Inferentia and AWS
EC2
AWS provides Yseop and its clients with a fully managed, private
cloud environment, which is of the highest importance in the
regulated life science industry.
About YseopYseop is the leader in Generative AI
for life science and pharmaceutical companies, changing the way
content automation solutions are delivered with a human-centric, AI
platform. Yseop is a pioneer in Natural Language Processing (NLP)
technology and acts as a “Copilot” for medical writers, maximizing
their efficiency and accuracy in generating reports and insights
crucial to drug development and approval. With cutting-edge
language models, Yseop ensures today’s pharmaceutical companies are
meeting the most demanding content tasks with ease, scalability and
application security. As the world’s leading content automation
solution for biopharmaceuticals, Yseop Copilot is a digital
colleague that empowers scientific writers and addresses the unique
requirements of the highly regulated pharmaceutical industry.
Blending the power of language models with customer data, Yseop
Copilot delivers trusted and auditable content automation solutions
in a closed, secure environment.
Media ContactMichael Canovayseop@fischtankpr.com